Central Garden & Pet Bolsa (NASDAQ: CENT)

Central Garden & Pet (NASDAQ:CENT) Bolsa

Central Garden & Pet

Central Garden & Pet Co understands that home is central to life and has nurtured happy and healthy homes for over forty years. The segments of the company are the pet segment and garden segment. The company's trusted products are dedicated to helping lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a portfolio of more than sixty-five brands including Pennington, Nylabone, Kaytee, Amdro, and Aqueon, manufacturing and distribution capabilities, and a passionate, entrepreneurial growth culture. Central Garden and Pet is based in Walnut Creek, California, and has offices across North America and Europe.

Central Garden & Pet Company - Common Stock

Central Garden & Pet Co

Central Garden & Pet Company - Class A Common Stock Nonvoting

CENTERGISTIC SLTNS INC by Centergistic Solutions, Inc.

CENTOGENE NV ORD

CENTR Brands Corp

The Central and Eastern Europe Fund, Inc. (The) Common Stock

CENTRAL & EASTERN EUROPE FUND, INC.

CENTRAL AUTOMOTIVE PRODS by Central Automotive Products Ltd.

CENTRAL CHINA SECS S/ADR by Central China Securities Co. Ltd.

CENTRAL CHNA NEW LIFE LTD by CENTRAL CHINA NEW LIFE LTD.

CENTRAL FLA ST BK BELLEVW by Central Florida State Bank (Belleview FL)

CENTRAL IRON ORE LIMITED by CENTRAL IRON ORE LIMITED

CENTRAL NEW ENERGY HLDG by CENTRAL NEW ENERGY HLDG GROUP LTD.

CENTRAL RETAIL CORP ADR by CENTRAL RETAIL CORP PUB CO LTD

Centamin PLC

Centaur Media PLC

CENTAURUS ENERGY INC by Centaurus Energy Inc.

Centaurus Energy Inc

CENTAURUS METALS LTD ORD by Centaurus Metals Ltd.

Centaurus Metals Ltd

CENTENARIO GOLD CORP by CENTENARIO GOLD CORP.

Centenario Gold Corp

Centene Corp

CENTENNIAL SPECIALTY FOOD by Centennial Specialty Foods Corp.

Centennial Specialty Foods Corp

CenterPoint Energy, Inc (Holding Co) Common Stock

CenterPoint Energy Inc

Centerra Gold Inc

Centerspace

Centessa Pharmaceuticals plc - American Depositary Shares

Centessa Pharmaceuticals PLC

Centogene NV

Centor Energy Inc

Centrais Electricas Brasileiras S A American Depositary Shares (Each representing one Common Share)

Centrais Eletricas Brasileiras SA

Centrais Electricas Brasileiras S.A. Sponsored ADS representing Pfd Shares

CENTRAL ASIA METALS LTD by Central Asia Metals Ltd, London

Central Asia Metals PLC

Central Bancompany

Central Bank Corp

CENTRAL CHINA MGMT CO LTD by CENTRAL CHINA MGMT CO LTD.

Central China Management Co Ltd

CENTRAL CHINA R E LTD ORD by Central China Real Estate Limited

Central China Real Estate Ltd

CENTRAL ENERGY PRTNRS LP by Central Energy Partners L.P.

Central Energy Partners LP

CENTRAL GLASS CO LTD ORD by Central Glass Co., Ltd.

Central Glass Co Ltd

CENTRAL JAPAN RY UNSP/ADR by Central Japan Railway Co.

Central Japan Railway Co

CENTRAL JAPAN RY ORD by Central Japan Railway Co.

CENTRAL NATURAL RES INC by Central Natural Resources, Inc.

Central Natural Resources Inc

Central Pacific Financial Corp

CENTRAL PRKNG F/T 5.25PFD by Central Parking Finance Trust

Central Parking Financial Trust

CENTRAL PATTANA NVDR by Central Pattana Plc.

Central Pattana PCL

CENTRAL PATTANA PUB CO by Central Pattana Plc.

CENTRAL PATTANA PLC ADR by Central Pattana Plc.

CENTRAL PETROLEUM LTD by Central Petroleum Ltd.

Central Petroleum Ltd

Central Plains Bancshares, Inc. - Common Stock

Central Plains Bancshares Inc

Central Puerto S.A. American Depositary Shares (each represents ten Common Shares)

Central Puerto SA

Central Securities Corporation Common Stock

Central Securities Corp

CENTRAL WIRELESS INC by Central Wireless, Inc.

Central Wireless Inc

Centrenergo PJSC

Centrica PLC

Centrifuge - United States dollar

Centrus Energy Corp. Class A Common Stock

Centrus Energy Corp

Centuri Holdings Inc

CENTURIA CAP GROUP UNITS by CENTURIA CAP GROUP

Centuria Capital Group

CENTURIA IND REIT ORD UTS by Centuria Indl Reit

Centuria Industrial REIT

Centuria Office REIT

Centurion Acquisition Corp. - Class A Ordinary Shares

Centurion Acquisition Corp

Century Aluminum Co

Century Casinos Inc

CENTURY COBALT CORP by Century Cobalt Corp.

Century Cobalt Corp

Century Communities Inc

CENTURY FINCL CORP MI by Century Financial Corp.

Century Financial Corp

CENTURY GLOBAL COM NEW by Century Global Commodities Corp

Century Global Commodities Corp

CENTURY LITHIUM CORP by CENTURY LITHIUM CORP.

Century Lithium Corp

CENTURY NEXT FINANCIAL CP by Century Next Financial Corp

Century Next Financial Corp

CENTURY PETROLEUM CORP by Century Petroleum Corp.

Century Petroleum Corp

Century Therapeutics, Inc. - Common Stock

Century Therapeutics Inc

WIIM

CENT

CENTA

Central Garden & Pet shares are trading higher after the company announced it raised its FY25 Non-GAAP EPS guidance.

Improved Outlook Driven by Strong Execution and Cost and Simplicity Initiatives Continued Focus on Strategic Investments to Drive Long-Term Profitable Growth Confidence in Central to Home Strategy and Opportunities Across Pet and Garden Segments
Central Garden &amp; Pet Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENT#NASDAQ">CENT</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENTA#NASDAQ">CENTA</a>) ("Central"), a leading company in the pet and garden industries, today announced that it has raised its outlook for fiscal 2025 non-GAAP earnings per share (EPS) to approximately $2.60.
Central anticipates fiscal 2025 capital expenditures of approximately $60 million.

News

Central Garden & Pet Raises FY25 Outlook Non-GAAP EPS To ~$2.60; Sees FY25 Capex of ~$60M

William E Brown, Chairman at Central Garden &amp; Pet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENT#NASDAQ">CENT</a>), executed a substantial insider sell on May 22, according to an SEC filing.
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0000887733/000095017025076491//Archives/edgar/data/887733/000095017025076491/0000950170-25-076491-index.htm">U.S. Securities and Exchange Commission</a> on Thursday showed that Brown sold 100,000 shares of Central Garden &amp; Pet. The total transaction amounted to $3,240,068. 
The latest update on Friday morning shows Central Garden &amp; Pet shares down by 0.0%, trading at $35.95.
<h3>All You Need to Know About Central Garden &amp; Pet</h3>
Central Garden &amp; Pet Co understands that home is central to life and has nurtured happy and healthy homes for over forty years. The segments of the company are the pet segment and garden segment. The company's trusted products are dedicated to helping lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a portfolio of more than sixty-five brands including Pennington, Nylabone, Kaytee, Amdro, and Aqueon, manufacturing and distribution capabilities, and a passionate, entrepreneurial growth culture. Central Garden and Pet is based in Walnut Creek, California, and has offices across North America and Europe.
<h3>A Deep Dive into Central Garden &amp; Pet's Financials</h3>
Revenue Growth: Central Garden &amp; Pet's revenue growth over a period of 3 months has faced challenges. As of 31 March, 2025, the company experienced a revenue decline of approximately -7.39%. This indicates a decrease in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Staples sector.
Insights into Profitability:
<ul>
<li>
Gross Margin: With a low gross margin of 32.76%, the company exhibits below-average profitability, signaling potential struggles in cost efficiency compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): Central Garden &amp; Pet's EPS lags behind the industry average, indicating concerns and potential challenges with a current EPS of 0.99.
</li>
</ul>
Debt Management: Central Garden &amp; Pet's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.92.
Market Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: The Price to Earnings ratio of 19.12 is lower than the industry average, indicating potential undervaluation for the stock.
</li>
<li>
Price to Sales (P/S) Ratio: With a P/S ratio of 0.75 below industry standards, the stock shows potential undervaluation, making it an appealing investment option for those focusing on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Central Garden &amp; Pet's EV/EBITDA ratio, lower than industry averages at 9.6, indicates attractively priced shares.
</li>
</ul>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Understanding the Significance of Insider Transactions</h3>
Insider transactions serve as a piece of the puzzle in investment decisions, rather than the entire picture.
Exploring the legal landscape, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated by Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and major hedge funds. These insiders are required to report their transactions through a Form 4 filing, which must be submitted within two business days of the transaction.
Highlighted by a company insider's new purchase, there's a positive anticipation for the stock to rise.
But, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>Deciphering Transaction Codes in Insider Filings</h3>
Surveying the realm of stock transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often give prominence to those unfolding in the open market, systematically detailed in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C denotes the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000887733">Check Out The Full List Of Central Garden &amp; Pet's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Trading Ideas

Insider Unloading: William E Brown Sells $3.24M Worth Of Central Garden & Pet Shares

Central Garden &amp; Pet (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cent#NASDAQ">CENT</a>) FY2025 expected to be more than $2.20 vs $2.36 Est.

Guidance

Central Garden & Pet FY2025 EPS Expected To Be More Than  $2.20 vs $2.36 Est

Central Garden &amp; Pet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENT#NASDAQ">CENT</a>) reported quarterly earnings of $1.04 per share which beat the analyst consensus estimate of $0.93 by 11.83 percent. This is a 5.05 percent increase over earnings of $0.99 per share from the same period last year. The company reported quarterly sales of $833.54 million which missed the analyst consensus estimate of $879.02 million by 5.17 percent. This is a 7.39 percent decrease over sales of $900.09 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

Central Garden & Pet Q2 Adj. EPS $1.04 Beats $0.93 Estimate, Sales $833.54M Miss $879.02M Estimate

ACAD

ACDC

ACRE

ACVA

ADMA

ADNT

ADTN

AIRG

ALNT

ALTG

ALTO

ALVO

AMPH

AMPL

AMRK

AMRN

AOSL

APLS

ARIS

ARMN

ASLE

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

AVDX

AXON

AXTA

AZTA

BAND

BBDO

BBGI

BBSI

BGSF

Brighthouse Financial, Inc. - Common Stock

BLBD

BLMN

BLZE

BMBL

BRKR

BROS

BTMD

BXSL

BYND

CAPL

CCSI

CDLX

CENX

CEVA

CIVI

CMTG

CNDT

COHR

Core Scientific, Inc. - Class A Common Stock

CORZ

CPRX

CRNC

CRNT

CSGS

CSTE

CTVA

CVNA

CYRX

Earnings Scheduled For May 7, 2025

Central Garden &amp; Pet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENT#NASDAQ">CENT</a>) will release its quarterly earnings report on Wednesday, 2025-05-07. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Central Garden &amp; Pet to report an earnings per share (EPS) of $0.94.
Anticipation surrounds Central Garden &amp; Pet's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Performance in Previous Earnings</h3>
The company's EPS beat by $0.25 in the last quarter, leading to a 8.34% increase in the share price on the following day.
Here's a look at Central Garden &amp; Pet's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.04</td>
<td>-0.20</td>
<td>1.21</td>
<td>0.80</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.21</td>
<td>-0.18</td>
<td>1.32</td>
<td>0.99</td>
</tr>
<tr>
<td>Price Change %</td>
<td>8.0%</td>
<td>3.0%</td>
<td>6.0%</td>
<td>11.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746540187_0.png" alt="eps graph" />
<h3>Central Garden &amp; Pet Share Price Analysis</h3>
Shares of Central Garden &amp; Pet were trading at $35.13 as of May 05. Over the last 52-week period, shares are down 17.35%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/CENT/earnings">To track all earnings releases for Central Garden &amp; Pet visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insights into Central Garden & Pet's Upcoming Earnings

ABEV

ANDE

BRBR

BRFS

CART

CASY

CELH

COCO

COKE

COST

COTY

FIZZ

Fomento Economico Mexicano S.A.B. De C.V.

Shares of consumer staple companies are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

Comments

Central Garden & Pet

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL